Tau is an intrinsically disordered microtubule-associated protein that is implicated in several neurodegenerative disorders called Tauopathies. In these diseases, Tau is found in the form of intracellular inclusions that consist of aggregated paired helical filaments (PHFs) in neurons.
INTRODUCTION
Microtubule associated protein Tau is known to play a vital role in cytoskeleton regulation by binding tubulin and thus controlling essential microtubule (MT) functions, from the necessary dynamic instability in dividing cells to axonal stability in neurons [1, 2] . Tau is also associated with a number of neurodegenerative diseases (ND) including Alzheimer's disease (AD), Parkinson's disease (PD), Pick's disease, Frontotemporal lobar degeneration (FLTD), Corticobasal degeneration and Progressive supranuclear palsy where it forms intracellular aggregates [3] [4] [5] [6] . These aggregates would spread in the brain through prion-like propagation [3, 7] . In the case of AD, Tau is believed to be the main factor underlying the development and progression of the pathology [8] . Different types of inclusions made of abnormal forms of Tau are found in different areas of the nervous system mostly in neuronal cells and, in some cases, in glial cells. The most common form of inclusions is called neurofibrillary tangles (NFTs). They are found in Alzheimer's disease, Parkinson's disease as well in other Tauopathies and consist of stacked paired helical filaments (PHFs) of hyper-phosphorylated Tau molecules [9] . In some diseases, Tau-mediated neuronal death can occur even in the absence of tangle formation [10] and it often aggregates with other teammates such as amyloid-β or α-Synuclein [11, 12] . Despite the extensive study of Tau aggregation over the last two decades, the exact causes of this process as well as its molecular mechanism are still not completely elucidated. PHF remains the most studied form of Tau aggregates. Among the endogenous factors that have been shown or suggested to favor Tau aggregation are post-transitional modifications (in particularly hyperphosphorylation), mutations and the presence of zinc ions [13] [14] [15] [16] . Interestingly, zinc ions were found to play a critical role in the development of several different neurodegenerative diseases including AD and PD. Zinc can bind not only to a number of prone-to-aggregate proteins implicated in neurodegeneration (such as amyloid-β [17] , FUS/TLS [18] , α-Synuclein [19] , TDP-43 [20, 21] etc.) and favor their aggregation, but also induce aggregation of stable proteins [22] .
The potential impact of zinc ions on Tau aggregation/oligomerization was first discovered in 2009 [23] . It was shown that low micromolar concentrations of zinc are able to accelerate the fibrillization of the 244-372 aa fragment of human Tau40 (hTau40), which consists of the four MTBR binding repeats R1, R2, R3 and R4 [23] . Similar results have been recently obtained on this same fragment lacking R3 repeat [24] . Nevertheless, both studies were carried out in the presence of heparin, which induces Tau fibrillization into ThT-positive paired helical filaments (PHFs). Recently, it was demonstrated that zinc not only accelerates aggregation of a pathological mutant ΔK280 of hTau40 induced by Congo red in vitro, but also significantly increases its toxicity in neuronal cells [25] . This study also demonstrated the importance of Cys-291 and Cys-322 residues both for zinc binding and Tau aggregation [23, 25] . While using nonphysiological specific inductors of Tau aggregation such as heparin or Congo red is the most common way to induce PHFs structure and test inhibitors, it might not be the most pertinent model to study PHF formation itself, especially in the early stages where the process has already been hypothesized to be reversible [26] . Also, it should be noted that in these studies the pathological aggregation in the presence of zinc were demonstrated for Tau mutants and fragments that could have higher propensity to aggregate in comparison with wild type human full-length Tau (hTau40).
Here, we have investigated aggregation of full-length human hTau40 isoform in the absence of heparin but in the presence of zinc ions under a wide range of temperature conditions using turbidimetry, isothermal titration calorimetry, dynamic light scattering and transmission electron microscopy. We found that, contrary to its aggregation in the presence of heparin or with other inducers such as arachidonic acid or congo red [25, 27, 28] , self-assembly of Tau is a reversible process that depends on temperature and is induced by zinc ions. Moreover, our findings point to an important role of low affinity auxiliary zinc-binding sites in this process.
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RESULTS
Zinc ions induce Tau oligomerization.
Turbidimetry was used to monitor the impact of zinc on Tau 
Thermodynamics of Tau-zinc interaction.
To verify if Tau oligomerization is directly linked to zinc binding, we investigated Tauzinc interaction using isothermal titration calorimetry (ITC) at different temperatures. In the turbidimetry experiments, at low temperatures we observed Tau aggregation only at high zinc concentrations (above 120 µM), but at high temperatures Tau aggregation started at an equimolar zinc concentration. ITC titration of 30 µM Tau solution by zinc at 10 and 45°C did not reveal significant differences in thermodynamic parameters of Tau-zinc interaction (Fig.2) indicating that zinc binds to tau just as well at 10°C than at 45°C. In both cases, fitting the binding isotherms using a two-sets-of-sites model revealed the existence of one high affinity site for zinc
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6 (N=1.0±0.1; K a =2.0±0.5×10 6 M -1 ) and three low affinity sites (N=3.2±0.3; K a =5.9±1.7×10 4 M -1 ).
The high affinity site was enthalpy driven but entropy unfavorable (∆H = -12.1±0.2 kcal M -1 ; ∆S = -13.8 cal M -1 K -1 ) probably due to partial folding of initially unstructured Tau molecule.
Meanwhile, the three low affinity sites were both enthalpy and entropy favorable (∆H = -1.8±0. 
Characterization of Tau oligomers.
To characterize the oligomers of Tau that form in the presence of zinc ions we used dynamic light scattering (DLS), transmission electron microscopy (TEM) and Thioflavin-T assay. DLS analysis of 30 µM Tau solution showed that, in the absence of zinc, at 10°C, Tau is mostly represented in solution as a species with a median hydrodynamic diameter of 9.6 ±1.4 nm by mass (Dv50, Table 1 ). Given that Tau is an intrinsically disordered protein, this size would correspond to the unfolded monomer [29] . Heating up to 40°C did not reveal significant conformational changes of the monomeric state of Tau (Table 1) , in agreement with our turbidimetry data.
To investigate the impact of zinc ions on the oligomeric state of Tau, 30 µM of Tau was titrated with up to a 4-fold molar excess of zinc at 40°C and analyzed by DLS ( Fig. 3A -C).
Within this range of zinc concentration, the main Tau species represented by mass had diameters ranging between from 10 to 12 nm. Furthermore, below the molar ratio Zn/Tau of 2.3 the polydispersity index remained low while Z-average (mean particle size) gradually increased ( Fig. 3C ; Table 1 ). Above this Zn/Tau ratio, Z-average started to increase together with the polydispersity indicating protein aggregation ( Fig. 3C ). Further increases in zinc concentration, up to excess of 4, led to a complete disappearance of low size species (Fig. 3A, B ) and the formation of oligomers too large to be properly monitored by DLS. Further investigation of formed structures by electron microscopy revealed the existence of large (>10 µm) aggregates When the temperature was then decreased from 40°C to 10°C, we observed the reappearance of low size species with a Dv50 of 11.3±2.5 nm in the presence of 120 µM zinc ( Table 1 ) which indicates that the oligomerization induced by zinc at 40°C is reversible.
Moreover, chelation of zinc ions with high excess of EDTA (2 mM) at 40°C also led to complete dissociation of aggregates, which returned to the same size distribution as it was before addition of zinc ions ( Table 1) . We have thus shown that reducing temperature can reverse the effect of zinc oligomerization of Tau and that removal of zinc at high temperatures can also reverse the oligomerization of Tau.
DISCUSSION
Zinc, which plays an important role in many physiological processes, has been implicated in the molecular mechanisms of many neurodegenerative diseases by favoring aggregation of proteins such as amyloid beta, FUS, TDP-43 [21, 30] . Recent in vitro studies showed that zinc could also impact Tau aggregation into PHF, a hallmark of several Tauopathies. Nevertheless, the conclusions from these studies were limited by the fact that the oligomerization of Tau into PHFs was induced by heparin.
Here, for the first time, we demonstrated that the presence of the zinc ions combined with increased temperature is sufficient to induce a fast oligomerization of Tau, and that it is reversible. Indeed, we have found that in the presence of equimolar zinc concentration, Tau oligomerizes at 50°C, while the increase of molar ratio of Zn/Tau to 2 decreases the temperature of oligomerization to 32°C (Fig. 1) , thus potentially impacting physiological function of Tau.
Similar interplay between ions and temperature of polymerization has already been observed in Fig.3B ). This suggests a partial folding of Tau with an increase in homogeneity as shown by the polydispersity index (Pdi). This is also in agreement with the unfavourable entropy of zinc binding found by ITC for this site. This first high affinity site likely corresponds to the one localized in the R2-R3
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Tau region in which zinc is chelated by two Cys and two His amino acids, as previously proposed [23, 25] . Such binding would be accompanied by the folding of Tau in R2-R3 as a hairpin, which is in good agreement with our DLS data that showed a compaction of the molecule. The three low affinity sites may be responsible for the oligomerization process.
Indeed, at 40°C we start to detect oligomerization by DLS at Zn/Tau around 2, when zinc starts to bind to these low affinity sites, as it can be seen from ITC titration curve (Fig 2) . Interestingly, the hydrodynamic size of Tau monomer species continues to decrease (down to 8.9±1.2 nm) as zinc binds to auxiliary sites, pointing to a further Tau folding (Fig. 3C ). This leads us to propose that zinc binding to both types of sites induces a structural change that may have a consequence on Tau physiological functions.
It should be stressed that, contrary to heparin-induced fibrillization of Tau in most PHF models, zinc-induced oligomerization of Tau is a reversible process with fast kinetics. Indeed,
9 chelation of zinc ions using EDTA, or a decrease of temperature instantly led to dissociation of oligomers. Contrary to ThT-positive irreversible aggregates formed in the presence of heparin, oligomers induced by zinc ions were not only reversible but also ThT-negative which indicates that the oligomers in the absence of heparin formed are not amyloid like. Most of the previous studies of Tau self-association in vitro were carried out in the presence of agents such as heparin or arachidonic acid [27, 28] and led to generation of irreversible structures. It has been hypothesized, and widely accepted, that irreversible Tau aggregation leading to PHFs found in neurons of patients affected with neurodegenerative disease would be preceded by a stage of reversible Tau multimers formation [26] . In our study, for the first time, we were able to reproduce a reversible oligomerization of Tau proteins in the presence of Zn without any additional non-physiological additives. Thus, our experimental conditions could constitute a useful model to study Tau multimerization in vitro.
The reversibility of Tau structures observed in our experiments also allows us to hypothesize that oligomers could be induced in cells by zinc signals under physiological conditions and play a role in Tau regulation, modulating its numerous functions [1] . For example, zinc was found to be involved in regulation of Tau interaction with DNA [32] . More generally, zinc is abundantly present in the brain where it plays an important role in axonal and synaptic transmission [33, 34] . It is highly concentrated in the synaptic vesicles of several types of neurons [35] . The majority of zinc ions in cell are bound to metalloproteins, which have metal binding affinities in the nM and even in pM range. The physiological concentration of free Zn 2+ in cells is considered to be between around 1-10 nM [36, 37] which locally would be sufficient to bind to Tau and modulate its activity. Thus, the observed binding constants that we determined are consistent with the possible physiological role of Zn in Tau regulation.
CONCLUSION
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In conclusion, we demonstrated for the first time that zinc can induce a reversible polymerization of Tau. This process could have a significant function in the brain and nervous system where zinc is known to be abundant. Our data, which demonstrate that zinc favors Tau self-assembly at near physiological temperatures, supports the idea that zinc could be implicated both in the pathological aggregation of Tau as well as in tau regulation. As summarized in figure   4 , while the right part depicts the irreversible cascade leading to the formation of neurofibrillary tangles, the left part depicts a pathway which would ultimately lead to the formation reversible granular aggregates of Tau which could have a sequestration purpose. Since tau phosphorylation is known to have physiological and pathological consequences [38] , impact of tau phosphorylation on this pathway will need to be addressed. We have also shown the existence of two types of sites (one main and three auxiliary ones) that gradually modulate Tau structure enabling zinc to be a subtle modulator of Tau activity. In order to understand how zinc ions can impact physiological Tau oligomerization, it will be important to identify the specific amino acids responsible for binding of those auxiliary zinc ions and the structure of such oligomers.
Likewise, confirming that this reversible oligomerization of Tau is part of a concurrent pathway will have important consequences in neurodegenerative disease research.
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MATERIALS AND METHODS
Protein purification
Human Tau (hTau40) was expressed in E. coli and purified as described previously [39] . Tau could thus be directly resuspended before use in the appropriate buffer. Protein was passed through the Zeba Spin Desalting Columns (Thermo Scientific) to equilibration in Tris 50 mM, TCEP 1mM, pH 7.5 buffer before being used for experiments. TCEP was used to maintain Tau in a reduced state. Its concentration was measured at 280 nm using extinction a coefficient of 7700 M -1 cm -1 [31] .
Isothermal Titration Calorimetry (ITC)
Binding of zinc to Tau was analyzed by ITC using MicroCal iTC200 as described previously [40, 41] . Experiments were performed at 10 and 45°C and in 50 mM Tris buffer in the presence 
Fluorescence Thioflavin T (ThT) assay
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ThT assay, which is a common marker of amyloid fibrils was performed as described before [42] with some modifications. Briefly, samples of 30 µM Tau alone or Tau with 8-fold excess of ZnCl 2 , were mixed with ThT. Fluorescence spectra were acquired in 0.2 (excitation direction) x 1 cm (emission) cells (Hellma) thermostated at 37°C ± 0.5°C without pre-incubation. Excitation was at 440 nm and emission spectra were recorded from 460 to 520 nm with slit widths of 15/15 nm using a Perkin-Elmer LS 55 fluorescence spectrometer operating at a PM of 800 V.
Transmission electron microscopy (TEM)
Four microliters of incubated Tau samples (30 µM) were placed on carbon-coated copper grids (300 mesh) during 1 min. After blotting, grids were washed with distilled water, and blotted again, negatively stained for 30 seconds with 2% (wt/vol) uranyl acetate as previously described [21] . The grids were then dried and observed with a JEOL 2200FS transmission electron microscope (Tokyo, Japan) operating at 200 kV. Images were recorded using a 4k × 4k slowscan CCD camera (Gatan, Inc. Pleasanton, USA). New oligomerization mechanism might be concurrent to PHF formation.
